Clinical and Laboratory Findings on the Differences Between H1N1 Influenza and Coronavirus Disease-2019 (COVID-19): Focusing on the Treatment Approach

Vakili, Sina; Akbari, Hamed; Jamalnia, Sheida

doi:10.1097/cpm.0000000000000362

Cited by 5 publications

(3 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As a global health warning introduced by WHO, the widespread COVID-19 pandemic has begun to turn into a new challenge with regard to determining the early diagnosis, isolation, and optimal treatment ( 2 , 20 , 21 , 22 ). RT-PCR as a laboratory technique and confirmed one is not empty of false-negative reports according to numerous reasons ( 23 ).…”

Section: Discussionmentioning

confidence: 99%

Differentiation of Chest CT Findings Between Influenza Pneumonia and COVID-19: Interobserver Agreement Between Radiologists

et al. 2021

View full text Add to dashboard Cite

Objectives To investigate the chest CT and clinical characteristics of COVID-19 pneumonia and H1N1 influenza, and explore the radiologist diagnosis differences between COVID-19 and influenza. Materials and methods This cross-sectional study included a total of 43 COVID-19-confirmed patients (24 men and 19 women, 49.90 ± 18.70 years) and 41 influenza-confirmed patients (17 men and 24 women, 61.53 ± 19.50 years). Afterwards, the chest CT findings were recorded and three radiologists recorded their diagnoses of COVID-19 or of H1N1 influenza based on the CT findings. Results The most frequent clinical symptom in patients with COVID-19 and H1N1 pneumonia were dyspnea (96.6%) and cough (62.5%), respectively. The CT findings showed that the COVID-19 group was characterized by GGO (88.1%), while the influenza group had features such as GGO (68.4%) and consolidation (66.7%). Compared with the influenza group, the COVID-19 group was more likely to have GGO (88.1% vs. 68.4%, p = 0.032), subpleural sparing (69.0% vs. 7.7%, p <0.001) and subpleural band (50.0% vs. 20.5%, p = 0.006), but less likely to have pleural effusion (4.8% vs. 33.3%, p = 0.001). The agreement rate between the three radiologists was 65.8%. Conclusion Considering similarities of respiratory infections especially H1N1 and COVID-19, it is essential to introduce some clinical and para clinical modalities to help differentiating them. In our study we extracted some lung CT scan findings from patients suspected to COVID-19 as a newly diagnosed infection comparing with influenza pneumonia patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Differentiation of Chest CT Findings Between Influenza Pneumonia and COVID-19: Interobserver Agreement Between Radiologists

et al. 2021

View full text Add to dashboard Cite

show abstract

“…T he coronavirus disease 2019 (COVID- 19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recognized as a worldwide pandemic and mostly affects the respiratory system [1][2][3]. Within two weeks of exposure to COVID-19, mild symptoms such as shortness of breath, cough, chills, fever, exhaustion, vomiting, nausea, congestion, sore throat, loss of smell and/or taste, headache, and body aches could appear [4][5][6][7].…”

Section: Introductionmentioning

confidence: 99%

Neurological Symptoms in Coronavirus Disease 2019 Patients: An Updated Literature Review

Mohammadi

Rostami

Naghdizadeh

et al. 2022

GMJ

View full text Add to dashboard Cite

Several studies have reported that coronavirus disease 2019 (COVID-19) can lead to multi-organ dysfunction. COVID-19 has been linked to a variety of neurological symptoms, according to the literature. The various paths via which the brain can be infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the symptoms of COVID-19 in neurological diseases, are discussed. COVID-19 symptoms have been observed in neurological illnesses such as epilepsy, ischemic stroke, multiple sclerosis, Alzheimer's disease, subarachnoid hemorrhage, Guillain–Barré syndrome, and Parkinson's disease in several investigations.

show abstract

“…T he coronavirus disease 2019 (COV-ID- 19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has now become a worldwide pandemic [1,2]. Although SARS-CoV-2 is primarily a respiratory pathogen, systemic organ involvement has been reported in many cases.…”

Section: Introductionmentioning

confidence: 99%

Digestive System Involvement During Coronavirus Disease 2019; the Newest Clinical Features and Potential Mechanisms

Kashkooli

Jooya

Navari

et al. 2022

GMJ

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been recognized as a worldwide pandemic and mostly affects the respiratory system. A considerable proportion of patients; however, might also experience gastrointestinal (GI) manifestations. Several investigations have assessed GI and hepatic involvement in this disease, although the mechanisms of these involvements in relation to the progression of COVID-19 remain unclear. This review summarized the clinical observations and the main mechanisms behind GI, liver, and pancreatic involvement among COVID-19 patients.

show abstract

Clinical and Laboratory Findings on the Differences Between H1N1 Influenza and Coronavirus Disease-2019 (COVID-19): Focusing on the Treatment Approach

Cited by 5 publications

References 38 publications

Differentiation of Chest CT Findings Between Influenza Pneumonia and COVID-19: Interobserver Agreement Between Radiologists

Differentiation of Chest CT Findings Between Influenza Pneumonia and COVID-19: Interobserver Agreement Between Radiologists

Neurological Symptoms in Coronavirus Disease 2019 Patients: An Updated Literature Review

Digestive System Involvement During Coronavirus Disease 2019; the Newest Clinical Features and Potential Mechanisms

Contact Info

Product

Resources

About